NCT05589701 Comparing SBRT to CRT in Patients With Spinal Metastases
| NCT ID | NCT05589701 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Health Network, Toronto |
| Condition | Spinal Metastases |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2022-12-12 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2022-12-12 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a single institutional registry-based, prospective, observational study to describe radiation oncologists' decision making during evaluation of patients and to compare real-world outcomes of SBRT vs CRT. A registry-based trial involves observing the effect of something without manipulating it.
Eligibility Criteria
Inclusion Criteria: * Adults 18 years of age or older. * Patients seen at the Princess Margaret Cancer Centre with painful spinal metastases amenable to radiation treatment. * Confirmation of diagnosis: a) Known/documented prior histological cancer diagnosis * Able to provide written consent * ECOG performance status 0-3 Exclusion Criteria: * Prior radiotherapy, with fields overlapping, resulting in excessive doses to organs at risk * Lymphoma, myeloma or germ cell malignancies
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05589701 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Spinal Metastases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05589701 currently recruiting?
Yes, NCT05589701 is actively recruiting participants. Contact the research team at david.shultz@rmp.uhn.ca for enrollment information.
Where is the NCT05589701 trial being conducted?
This trial is being conducted at Toronto, Canada.
Who is sponsoring the NCT05589701 clinical trial?
NCT05589701 is sponsored by University Health Network, Toronto. The trial plans to enroll 100 participants.